Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.
Menu

Researcher Publications

Gregory M. Riedlinger, MD, PhD

Selected Publications

  1. Panda A, de Cubas AA, Stein M, Riedlinger G, Smith CC, Kra J, Mayer T, Vincent BG, Serody JS, Beckerman KE, Ganesan S, Bhanot G, Rathmell WK. Endogenous retrovirus expression is associated with response to immune checkpoint inhibition in clear-cell renal cell carcinoma. JCI Insight. 2018 Aug 23;3(16). pii: 121522.
  2. Severson EA*, Riedlinger GM*, Connelly CF*, Vergilio JA, Goldfinger M, Ramkissoon S, Frampton GM, Ross JS, Fratella-Calabrese A, Gay L, Ali S, Miller V, Elvin J, Hadigol M, Hirshfield KM, Rodriguez-Rodriguez L, Ganesan S, Khiabanian H. Detection of Clonal Hematopoiesis of Indeterminate Potential in Clinical Sequencing of Solid Tumor Specimens. Blood. 2018 May 31;131(22):2501-2505 *contributed equally
  3. Dhami J, Hirshfield KM, Ganesan S, Hellmann M, Rojas V, Amorosa JK, Riedlinger GM, Zhong H, Ali SM, Pavlick D, Elvin JA, Rodriguez-Rodriguez L. Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer. Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2)
  4. Mon S, Riedlinger G, Abbott CE, Seethala R, Ohori NP, Nikiforova MN, Nikiforov YE, Hodak SP. Cancer Risk and Clinicopathological Characteristics of Thyroid Nodules Harboring Thyroid-Stimulating Hormone Receptor (TSHR) Gene Mutations. Diagn Cytopathol. 2018 Mar 8..
  5. Panda A, Mehnert JM, Hirshfield KM, Riedlinger GM, Damare S, Saunders T, Kane M, Sokol S, Stein MN, Poplin E, Rodriguez-Rodriguez L, Silk A, Aisner J, Chan N, Malhotra J, Frankel M, Kaufman HL, Ali S, Ross JS, White EP, Bhanot G, Ganesan S. Immune activation and response to avelumab (PD-L1 antibody) in a patient with metastatic EBV-positive gastric cancer. J Natl Cancer Inst. 2018 Mar 1;110(3):316-320.
  6. Luo Y, Riedlinger G, Szolovits P. Text mining in cancer gene and pathway prioritization. Cancer . 2014 Oct; 13(Suppl 1) 69-79.
  7. Quinn A, Klepeis V, Mandelker D, Platt M, Rao L, Riedlinger G, Baron JM, Brodsky V, Kim JY, Lane WJ, Lee RE, Levy BP, McClintock D, Beckwitt BA, Kuo F, Gilbertson JR. The ongoing evolution of the core curriculum of a clinical pathology informatics fellowship. J Pathol Inform. 2014 Jul; 30:5-22.
  8. Mandelker D, Lee RE, Platt M, Riedlinger G, Quinn A, Rao L, Klepeis V, Mahowald M, Lane WJ, Beckwitt BA, Baron JM, Le LP, McClintock D, Iafrate AJ, Lindeman NI, Dighe AS, Kuo F, Lebo MS, Gilbertson JR. Pathology informatics fellowship training: Focus on molecular pathology. J Pathol Inform. 2014 Mar; 28:5-11.
  9. Sugui JA, Peterson SW, Clark LP, Nardone G, Folio L, Riedlinger G, Zerbe CS, Shea Y, Henderson CM, Zelazny AM, Holland SM, Kwon-Chung KJ. Aspergillus tanneri sp. nov., a new pathogenic Aspergillus that causes invasive disease refractory to antifungal therapy. J Clin Microbiol. 2012 Oct;50(10):3309-17.
  10. Yu JH, Zhu BM, Riedlinger G, Kang K, Hennighausen L. The liver-specific tumor suppressor STAT5 controls expression of the ROS generating enzyme NOX4 and the pro-apoptotic proteins PUMA and BIM. Hepatology. 2012 Jun 18; 56(6):2375-86.

For additional publications, see https://www.ncbi.nlm.nih.gov/pubmed/?term=riedlinger+g

Return to member profile